Login
$PTCT
$60.97 -$2.52 (3.97%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Matthew B. Klein, M.D., M.S., F.A.C.S. Also a director
CHIEF EXECUTIVE OFFICER
Title from the Form 4 dated Aug 4, 2026
54 Not stated Not stated $23,266,326
Pierre Gravier
Chief Financial Officer
41 Since 2023
3 years
Not stated $3,550,786
Neil Almstead
Chief Technical Operations Officer
59 Since 2018
8 years
2000 $3,159,055
Mark E. Boulding
Executive Vice President and Chief Legal Officer
65 Since 2012
14 years
2002 Not reported
Lee Golden, M.D.
Executive Vice President and Chief Medical Officer
58 Since 2023
3 years
Not stated $3,269,179
Eric Pauwels
Chief Business Officer
65 Since 2020
6 years
2015 $3,562,968
Christine Utter
SVP, CHIEF ACCOUNTING OFFICER
Title from the Form 4 dated Jun 17, 2026
48 Not stated 2010 Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 20, 2026 · updated by the 8-Ks of Jun 9, 2026 and Jul 30, 2026

Directors
10
serving now
Independent
8 of 8
stated in the proxy; 2 not stated
Average tenure
13.7 years
from year joined
CEO also chairs the board
No
Michael Schmertzler
Director Age On board Independent Committees Other public boards 2025 pay Source
Michael Schmertzler
74 2001
25 years
Independent
Development Committee
None stated $896,310
Matthew B. Klein, M.D., M.S., F.A.C.S.
54 2023
3 years
Not stated None stated ClearPoint Neuro, Inc. Paid as CEO
Stephanie S. Okey, M.S.
66 2018
8 years
Independent None stated Crinetics Pharmaceuticals, Inc. $471,905
Jerome B. Zeldis, M.D., Ph.D.
76 2012
14 years
Independent
Nominating and Corporate Governance Committee
Soligenix, Inc. $463,905
Emma Reeve
65 2018
8 years
Independent
Audit Committee · Chair
Whitehawk Therapeutics, Inc. $507,405
Mary Smith
63 2021
5 years
Independent
Audit Committee
None stated $479,405
Glenn D. Steele Jr., M.D., Ph.D.
81 2015
11 years
Independent
Compensation Committee · Chair
None stated $477,405
Allan Jacobson, Ph.D.
80 1998
28 years
Independent
Development Committee · Chair
None stated $547,405
David P. Southwell
65 2005
21 years
Independent
Compensation Committee
Rocket Pharmaceuticals $494,405
Hege Sollie-Zetlmayer Joined Jul 28, 2026
- - - - - -
Nominated to join at the meeting
Not on the board yet; they join only if elected.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

3 disclosed in the proxy filed Apr 20, 2026
Jane (Zheng) Yang Almstead
the wife of Neil Almstead, our Chief Technical Operations Officer
$263,133.98
fiscal 2025

Employed by the Company as a Principal Scientist, Analytical Development, with compensation for fiscal 2025.

Matthew B. Klein
Chief Executive Officer of the Company; was Chief Executive Officer and director of BioElectron and remains a shareholder of BioElectron
Amount not stated

Company acquired substantially all assets of BioElectron under an Asset Purchase Agreement; Dr. Klein owns about six percent of BioElectron and is entitled to a portion of payments made to BioElectron under that agreement.

With BioElectron Technology Corporation Open in proxy
Directors and executive officers
directors and executive officers of the Company
Amount not stated

Indemnification agreements under which the Company may indemnify directors and executive officers for expenses, judgments, fines and settlement amounts arising from their service.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support